BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10926380)

  • 21. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhalation therapy during mechanical ventilation.
    Cakar N
    Intensive Care Med; 1999 Feb; 25(2):233-5. PubMed ID: 10193556
    [No Abstract]   [Full Text] [Related]  

  • 23. Which dry powder inhaler should be chosen?
    Kuziemski K
    Respiration; 2009; 78(3):356; author reply 357-8. PubMed ID: 19602872
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recommendations of the German Respiratory League for treatment of patients with chronic obstructive bronchitis and pulmonary emphysema].
    Wettengel R; Böhning W; Cegla U; Criée C; Fichter J; Geisler L; Fabel H; Köhler D; Konietzko N; Lindemann H
    Med Klin (Munich); 1995 Jan; 90(1):3-7. PubMed ID: 7885301
    [No Abstract]   [Full Text] [Related]  

  • 25. Aerosol delivery devices and obstructive airway disease.
    O'Riordan TG
    Expert Rev Med Devices; 2005 Mar; 2(2):197-203. PubMed ID: 16293056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebuliser therapy.
    Esmond G
    Prof Nurse; 1998 Oct; 14(1):39-43. PubMed ID: 9866617
    [No Abstract]   [Full Text] [Related]  

  • 28. Adaptive Aerosol Delivery (AAD) technology.
    Denyer J; Nikander K; Smith NJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):165-76. PubMed ID: 16296727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro characterisation of the nebulised dose during non-invasive ventilation.
    Abdelrahim ME; Plant P; Chrystyn H
    J Pharm Pharmacol; 2010 Aug; 62(8):966-72. PubMed ID: 20663030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerosol therapy: nebulizer vs metered dose inhaler.
    Newhouse M; Dolovich M
    Chest; 1987 Jun; 91(6):799-800. PubMed ID: 3581925
    [No Abstract]   [Full Text] [Related]  

  • 31. Aerosol generators and delivery systems.
    Newman SP
    Respir Care; 1991 Sep; 36(9):939-51. PubMed ID: 10145539
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dynamic action of nebulizers and the influence of breathing technic on the deposition of aerosolized drugs].
    Wolf M; Angerstein W
    Z Erkr Atmungsorgane; 1982; 159(2):215-20. PubMed ID: 7168216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paediatric pulmonary drug delivery: considerations in asthma treatment.
    Berger WE
    Expert Opin Drug Deliv; 2005 Nov; 2(6):965-80. PubMed ID: 16296802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of inhalation of a glucocorticoid using metered-dose propellant gas aerosol and Turbohaler--a roentgen pilot study].
    Vogel H; Wettmarshausen C
    Pneumologie; 1995 Oct; 49(10):559-60. PubMed ID: 8584527
    [No Abstract]   [Full Text] [Related]  

  • 35. Dry powder inhalers: an overview.
    Atkins PJ
    Respir Care; 2005 Oct; 50(10):1304-12; discussion 1312. PubMed ID: 16185366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA approves new inhaler without CFCs.
    FDA Consum; 2001; 35(4):3. PubMed ID: 11692883
    [No Abstract]   [Full Text] [Related]  

  • 37. Geriatrics for the clinician. Inhalation therapy and the elderly: what every physician should consider.
    Tsoukleris MG; Michocki RJ
    Md Med J; 1995 Dec; 44(12):1049-52. PubMed ID: 8544672
    [No Abstract]   [Full Text] [Related]  

  • 38. [Obstructive respiratory tract diseases. Diagnosis and principles of therapy].
    Heinl KW
    Med Monatsschr Pharm; 1989 Nov; 12(11):338-43. PubMed ID: 2685525
    [No Abstract]   [Full Text] [Related]  

  • 39. Strategy for the in vitro testing of spacers and holding chambers that may be used with young children.
    Mitchell JP; Nagel MW
    J Aerosol Med; 1998; 11 Suppl 1():S53-8. PubMed ID: 10180733
    [No Abstract]   [Full Text] [Related]  

  • 40. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.
    Knoch M; Keller M
    Expert Opin Drug Deliv; 2005 Mar; 2(2):377-90. PubMed ID: 16296761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.